Atlas Trials

Diaphragm Function After Reversal of Rocuronium-induced Neuromuscular Blockade With Sugammadex or Neostigmine in Children

Clinical trial NCT05724550 · COMPLETED

Trial details

NCT number
NCT05724550
Sponsor
Seoul National University Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Neuromuscular Block, Residual
Start date
2023-02-22
Primary completion
2024-06-07
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.